Cargando…

Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure

Support measures currently represent the mainstay of treatment for fulminant myocarditis, while effective and safe anti-inflammatory therapies remain an unmet clinical need. However, clinical and experimental evidence indicates that inhibition of the pro-inflammatory cytokine interleukin 1 (IL-1) is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavalli, Giulio, Foppoli, Marco, Cabrini, Luca, Dinarello, Charles A., Tresoldi, Moreno, Dagna, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298961/ https://www.ncbi.nlm.nih.gov/pubmed/28232838 http://dx.doi.org/10.3389/fimmu.2017.00131

Ejemplares similares

Myocarditis: An Interleukin-1-Mediated Disease?
por: De Luca, Giacomo, et al.
Publicado: (2018)

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim–Chester Disease
por: Tomelleri, Alessandro, et al.
Publicado: (2018)

Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
por: De Luca, Giacomo, et al.
Publicado: (2021)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021)

Oncogene-Induced Senescence as a New Mechanism of Disease: The Paradigm of Erdheim–Chester Disease
por: Cavalli, Giulio, et al.
Publicado: (2014)

Why not treat human cancer with interleukin-1 blockade?
por: Dinarello, Charles A.
Publicado: (2010)

Interleukin-18 and IL-18 Binding Protein
por: Dinarello, Charles A., et al.
Publicado: (2013)

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
por: Cavalli, Giulio, et al.
Publicado: (2020)

Checkpoint Blockade Rescues the Repressive Effect of Histone Deacetylases Inhibitors on γδ T Cell Function
por: Bhat, Sajad A., et al.
Publicado: (2018)

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
por: Cavalli, Giulio, et al.
Publicado: (2021)

Interleukin-37 Inhibits Colon Carcinogensis During Chronic Colitis
por: Mountford, Steffeni, et al.
Publicado: (2019)

Circulating interleukin-38 concentrations in healthy adults
por: Teufel, Lisa U., et al.
Publicado: (2022)

Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness
por: Cavalli, Giulio, et al.
Publicado: (2020)

The right place for IL-1 inhibition in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021)

The course of action for effective anti-cytokine treatment in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021)

Modulation of Liver Inflammation and Fibrosis by Interleukin-37
por: Mountford, Steffeni, et al.
Publicado: (2021)

The Rate of Interleukin-1β Secretion in Different Myeloid Cells Varies with the Extent of Redox Response to Toll-like Receptor Triggering
por: Carta, Sonia, et al.
Publicado: (2011)

Subtyping based on immune cell fractions reveal heterogeneity of cardiac fibrosis in end-stage heart failure
por: Zou, Shangjie, et al.
Publicado: (2023)

Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis
por: Wang, Runsheng, et al.
Publicado: (2021)

The Spectrum of COVID-19-Associated Myocarditis: A Patient-Tailored Multidisciplinary Approach
por: Peretto, Giovanni, et al.
Publicado: (2021)

The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines
por: Kim, Busun, et al.
Publicado: (2013)

Rare case of chronic Q fever myocarditis in end stage heart failure patient: A case report
por: Goyal, Amandeep, et al.
Publicado: (2022)

The Expanding Therapeutic Perspective of CCR5 Blockade
por: Vangelista, Luca, et al.
Publicado: (2018)

Smoldering myocarditis following immune checkpoint blockade
por: Norwood, Timothy G., et al.
Publicado: (2017)

Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis
por: Peretto, Giovanni, et al.
Publicado: (2022)

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
por: De Luca, Giacomo, et al.
Publicado: (2020)

Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases
por: Cavalli, Giulio, et al.
Publicado: (2019)

Anakinra Therapy for Non-cancer Inflammatory Diseases
por: Cavalli, Giulio, et al.
Publicado: (2018)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Blockade of Neutrophil’s Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure
por: Khanam, Arshi, et al.
Publicado: (2017)

Grand Challenge in Inflammation
por: Dinarello, Charles A.
Publicado: (2012)

Review of Tissue-Protective Cytokines
por: Dinarello, Charles A.
Publicado: (2013)

Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle
por: Farina, Nicola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bej4kuvu6sat1d2psfsaqm7vp6